BTIG Reiterates Foghorn Therapeutics (FHTX) at Buy, "one of our 1H26 Top Picks"
Tweet Send to a Friend
BTIG analyst Jeet Mukherjee reiterated a Buy rating and $11.00 price target on Foghorn Therapeutics (NASDAQ: FHTX).The analyst commented: "FHTX ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
